cefoperazone has been researched along with edetic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ahlmén, J; Alestig, K; Trollfors, B | 1 |
| Crosby, MA; Gump, DW | 1 |
1 review(s) available for cefoperazone and edetic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cefoperazone and edetic acid
| Article | Year |
|---|---|
Renal function during cefoperazone treatment.
Topics: Adult; Aged; Bacterial Infections; beta 2-Microglobulin; Cefoperazone; Cephalosporins; Edetic Acid; Female; Glomerular Filtration Rate; Half-Life; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged | 1982 |
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
Topics: Anti-Bacterial Agents; Bacteroides; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cell Membrane Permeability; Cephalosporins; Clavulanic Acids; Drug Synergism; Edetic Acid; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1982 |